Next Article in Journal
Long Non-Coding RNAs in Endometrial Carcinoma
Previous Article in Journal
Alzheimer’s Disease: Mechanism and Approach to Cell Therapy
Open AccessArticle

The Estrogen Receptor-β Expression in De Quervain’s Disease

1
Department of Orthopedics, Tainan Hospital, Ministry of Health and Welfare, Tainan 70043, Taiwan
2
Department of Orthopedics, Chi-Mei Medical Center, Tainan 71004, Taiwan
3
Department of Orthopedics, National Cheng Kung University College of Medicine, 1 Dashuei Road, Tainan 70101, Taiwan
4
Department of Orthopedics, Kuo’s General Hospital, Tainan 70054, Taiwan
5
Department of Nursing, Chung Hwa University of Medical Technology, 89 Wenhua 1st Street, Rende District, Tainan 71703, Taiwan
*
Authors to whom correspondence should be addressed.
Academic Editor: Kurt A. Jellinger
Int. J. Mol. Sci. 2015, 16(11), 26452-26462; https://doi.org/10.3390/ijms161125968
Received: 3 September 2015 / Revised: 22 October 2015 / Accepted: 29 October 2015 / Published: 4 November 2015
(This article belongs to the Section Biochemistry)
Stenosing tenosynovitis of the first dorsal compartment of the wrist (a.k.a. de Quervain’s disease) is common but how estrogen is involved is still unknown. We previously reported that inflammation was involved in the pathogenesis of this ailment. In the present study, we extended our investigation of estrogen receptor (ER)-β expression to determine whether estrogen is involved in the pathogenesis of de Quervain’s. Intraoperative retinaculum samples were collected from 16 patients with the ailment. Specimens were histologically graded by collagen structure and immunohistochemically evaluated by quantifying the expression of ER-β, interleukin (IL)-1β and IL-6 (inflammatory cytokines), cyclooxygenase (COX)-2 (an inflammatory enzyme), and vascular endothelial growth factor (VEGF), and Von Willebrand’s factor (vWF). De Quervain’s occurs primarily in women. The female:male ratio in our study was 7:1. We found that ER-β expression in the retinaculum was positively correlated with disease grade and patient age. Additionally, disease severity was associated with inflammatory factors—IL-1β and IL-6, COX-2, and VEGF and vWF in tenosynovial tissue. The greater the levels of ER-β expression, tissue inflammation, and angiogenesis are, the more severe de Quervain’s disease is. ER-β might be a useful target for novel de Quervain’s disease therapy. View Full-Text
Keywords: estrogen receptor-β; de Quervain’s disease; inflammation; angiogenesis estrogen receptor-β; de Quervain’s disease; inflammation; angiogenesis
Show Figures

Figure 1

MDPI and ACS Style

Shen, P.-C.; Wang, P.-H.; Wu, P.-T.; Wu, K.-C.; Hsieh, J.-L.; Jou, I-M. The Estrogen Receptor-β Expression in De Quervain’s Disease. Int. J. Mol. Sci. 2015, 16, 26452-26462. https://doi.org/10.3390/ijms161125968

AMA Style

Shen P-C, Wang P-H, Wu P-T, Wu K-C, Hsieh J-L, Jou I-M. The Estrogen Receptor-β Expression in De Quervain’s Disease. International Journal of Molecular Sciences. 2015; 16(11):26452-26462. https://doi.org/10.3390/ijms161125968

Chicago/Turabian Style

Shen, Po-Chuan; Wang, Ping-Hui; Wu, Po-Ting; Wu, Kuo-Chen; Hsieh, Jeng-Long; Jou, I-Ming. 2015. "The Estrogen Receptor-β Expression in De Quervain’s Disease" Int. J. Mol. Sci. 16, no. 11: 26452-26462. https://doi.org/10.3390/ijms161125968

Find Other Styles

Article Access Map by Country/Region

1
Only visits after 24 November 2015 are recorded.
Search more from Scilit
 
Search
Back to TopTop